⌘K

Login Start Free

Home/Filings/4/0001144204-16-088709

4//SEC Filing

Celator Pharmaceuticals Inc 4

Accession 0001144204-16-088709

CIK 0001327467operating

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 4:59 PM ET

Size

9.6 KB

Accession

0001144204-16-088709

Insider Transaction Report

Form 4

Period: 2016-03-15

Celator Pharmaceuticals IncCPXX

Mayer Lawrence David

President and Head of Research

Transactions

Tax Payment
Common Stock
2016-03-15$8.94/sh−12,081$108,004→ 107,515 total
Exercise/Conversion
Common Stock
2016-03-15$2.25/sh+48,002$108,005→ 119,596 total
Exercise/Conversion
Stock Option, Right to Buy
2016-03-15−48,002→ 0 total
Exercise: $2.25Exp: 2016-03-22→ Common Stock (48,002 underlying)

Holdings

Common Stock
(indirect: By Spouse)
7,468
Common Stock
(indirect: By Trust)
3,631

Footnotes (1)

[F1]These options are fully exercisable.

Documents

1 file

4
v434636_4.xmlPrimary
FORM 4

Issuer

Celator Pharmaceuticals Inc

CIK 0001327467

Entity typeoperating

Related Parties

1

filerCIK 0001327467

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 4:59 PM ET
Size: 9.6 KB

View on SEC.gov